Gene Symbol | IGF2 |
Entrez ID | 3481 |
Uniprot ID | P01344 |
Description | insulin like growth factor 2 |
Chromosomal Location | chr11: 2,129,112-2,141,238 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0001501 |
skeletal system development |
The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton). |
TAS |
BP |
GO:0001503 |
ossification |
The formation of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone or a bony substance. |
IEA |
BP |
GO:0001934 |
positive regulation of protein phosphorylation |
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein. |
ISS |
BP |
GO:0002576 |
platelet degranulation |
The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet. |
TAS |
BP |
GO:0006006 |
glucose metabolic process |
The chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. D-glucose is dextrorotatory and is sometimes known as dextrose; it is an important source of energy for living organisms and is found free as well as combined in homo- and hetero-oligosaccharides and polysaccharides. |
IEA |
BP |
GO:0006349 |
regulation of gene expression by genetic imprinting |
Heritable alterations in the activity of a gene that depend on whether it passed through the paternal or the maternal germline, but that are not encoded by DNA itself. |
TAS |
BP |
GO:0006355 |
regulation of transcription, DNA-templated |
Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription. |
NAS |
BP |
GO:0007275 |
multicellular organism development |
The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult). |
TAS |
BP |
GO:0008284 |
positive regulation of cell proliferation |
Any process that activates or increases the rate or extent of cell proliferation. |
IC |
BP |
GO:0008286 |
insulin receptor signaling pathway |
The series of molecular signals generated as a consequence of the insulin receptor binding to insulin. |
TAS |
BP |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase |
The series of molecular signals generated as a consequence of the insulin receptor binding to its physiological ligand, where the signal is passed on via the phosphatidylinositol 3-kinase cascade. |
ISS |
BP |
GO:0042104 |
positive regulation of activated T cell proliferation |
Any process that activates or increases the rate or extent of activated T cell proliferation. |
IDA |
BP |
GO:0043085 |
positive regulation of catalytic activity |
Any process that activates or increases the activity of an enzyme. |
ISS |
BP |
GO:0043410 |
positive regulation of MAPK cascade |
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade. |
IDA |
BP |
GO:0044267 |
cellular protein metabolic process |
The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification. |
TAS |
BP |
GO:0045725 |
positive regulation of glycogen biosynthetic process |
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of glycogen. |
ISS |
BP |
GO:0045840 |
positive regulation of mitotic nuclear division |
Any process that activates or increases the frequency, rate or extent of mitosis. |
IDA |
BP |
GO:0046628 |
positive regulation of insulin receptor signaling pathway |
Any process that increases the frequency, rate or extent of insulin receptor signaling. |
IDA |
BP |
GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation |
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine. |
ISS |
BP |
GO:0051781 |
positive regulation of cell division |
Any process that activates or increases the frequency, rate or extent of cell division. |
IEA |
BP |
GO:0051897 |
positive regulation of protein kinase B signaling |
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B. |
IDA |
BP |
GO:0071902 |
positive regulation of protein serine/threonine kinase activity |
Any process that increases the rate, frequency, or extent of protein serine/threonine kinase activity. |
IEA |
BP |
GO:2000273 |
positive regulation of receptor activity |
Any process that activates or increases the frequency, rate or extent of receptor activity. |
IEA |
BP |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity |
Any process that activates or increases the frequency, rate or extent of glycogen (starch) synthase activity. |
ISS |
CC |
GO:0005576 |
extracellular region |
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
TAS |
CC |
GO:0005615 |
extracellular space |
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
IEA |
CC |
GO:0005886 |
plasma membrane |
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
TAS |
CC |
GO:0031093 |
platelet alpha granule lumen |
The volume enclosed by the membrane of the platelet alpha granule. |
TAS |
CC |
GO:0070062 |
extracellular exosome |
A membrane-bounded vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
IDA |
MF |
GO:0005158 |
insulin receptor binding |
Interacting selectively and non-covalently with the insulin receptor. |
IPI |
MF |
GO:0005159 |
insulin-like growth factor receptor binding |
Interacting selectively and non-covalently with the insulin-like growth factor receptor. |
IMP |
MF |
GO:0005179 |
hormone activity |
The action characteristic of a hormone, any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action. The term was originally applied to agents with a stimulatory physiological action in vertebrate animals (as opposed to a chalone, which has a depressant action). Usage is now extended to regulatory compounds in lower animals and plants, and to synthetic substances having comparable effects; all bind receptors and trigger some biological process. |
IEA |
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
MF |
GO:0008083 |
growth factor activity |
The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation. |
IDA |
MF |
GO:0030546 |
receptor activator activity |
The function of interacting (directly or indirectly) with receptors such that the proportion of receptors in the active form is increased. |
ISS |
MF |
GO:0043539 |
protein serine/threonine kinase activator activity |
Binds to and increases the activity of a protein serine/threonine kinase. |
ISS |
Domain ID | Description |
---|---|
IPR013576 |
Insulin-like growth factor II E-peptide, C-terminal |
IPR016179 |
Insulin-like |
IPR022334 |
Insulin-like growth factor II |
IPR022350 |
Insulin-like growth factor |
IPR022352 |
Insulin family |
IPR022353 |
Insulin, conserved site |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa05205 |
Proteoglycans in cancer |
KEGG |
WP3584 |
MECP2 and Associated Rett Syndrome |
WikiPathways |
WP474 |
Endochondral Ossification |
WikiPathways |
WP254 |
Apoptosis |
WikiPathways |
WP2406 |
Cardiac Progenitor Differentiation |
WikiPathways |
UMLS CUI | UMLS Term |
---|---|
C0000786 |
Spontaneous Abortion |
C0002395 |
Alzheimer'S Disease |
C0002871 |
Anemia |
C0004153 |
Atherosclerosis |
C0004352 |
Autistic Disorder |
C0004903 |
Beckwith-Wiedemann Syndrome |
C0005941 |
Bone Diseases, Developmental |
C0009241 |
Cognition Disorders |
C0009375 |
Colonic Neoplasms |
C0009404 |
Colorectal Neoplasms |
C0011854 |
Diabetes Mellitus, Insulin-Dependent |
C0015934 |
Fetal Growth Retardation |
C0018273 |
Growth Disorders |
C0019284 |
Diaphragmatic Hernia |
C0020224 |
Polyhydramnios |
C0020615 |
Hypoglycemia |
C0023903 |
Liver Neoplasms |
C0025261 |
Memory Disorders |
C0027708 |
Nephroblastoma |
C0027746 |
Nerve Degeneration |
C0028754 |
Obesity |
C0030567 |
Parkinson Disease |
C0032045 |
Placenta Disorders |
C0032927 |
Precancerous Conditions |
C0035412 |
Rhabdomyosarcoma |
C0175693 |
Russell-Silver Syndrome |
C0206624 |
Hepatoblastoma |
C0206686 |
Adrenocortical Carcinoma |
C0752347 |
Lewy Body Disease |
C2239176 |
Liver Carcinoma |
Tissue | Cell Type |
---|---|
placenta |
trophoblastic cells |
Database Name |
---|
PhenomicDB |
OMIM |
DisGeNET |
DISEASES |
DGA |
Pubmed ID | Author | Year | Title |
---|---|---|---|
22951915 |
Haozi et al. |
2012 |
Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome |
25393639 |
Ambekar et al. |
2014 |
Proteomics of follicular fluid from women with polycystic ovary syndrome suggests molecular defects in follicular development |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
IGF1R |
3480 |
P08069 |
0.52 |
PLG |
5340 |
P00747 |
0.52 |
DCN |
1634 |
P07585 |
0.63 |
BAG6 |
7917 |
P46379 |
0.63 |
RBPMS |
11030 |
Q93062 |
0.63 |
FAF1 |
11124 |
Q9UNN5 |
0.63 |
NMRK2 |
27231 |
Q9NPI5 |
0.63 |
CRELD2 |
79174 |
Q6UXH1 |
0.63 |
IGFBP2 |
3485 |
P18065 |
0.66 |
IDE |
3416 |
P14735 |
0.75 |
IGFBP1 |
3484 |
P08833 |
0.75 |
IGFBP4 |
3487 |
P22692 |
0.85 |
IGFBP6 |
3489 |
P24592 |
0.85 |
IGFBP3 |
3486 |
P17936 |
0.86 |
IGFBP5 |
3488 |
P24593 |
0.86 |
IGF2R |
3482 |
P11717 |
0.90 |
GPC3 |
2719 |
P51654 |
0.52 |
INSR |
3643 |
P06213 |
0.52 |
PCSK4 |
54760 |
Q6UW60 |
0.55 |
IGFBP7 |
3490 |
Q16270 |
0.75 |
TF |
7018 |
P02787 |
0.75 |
NOV |
4856 |
P48745 |
0.85 |
VTN |
7448 |
P04004 |
0.85 |